Lam Research has approved a US$25 billion share repurchase authorisation alongside a US$0.33 quarterly dividend, giving investors a sizeable new capital-return commitment but no guarantee of when shares will be bought. Shareholders also re-elected the board and rejected a proposal to make special meetings easier to call.
- US$25 billion buyback authorisation supplements prior balances
- US$0.33 quarterly dividend payable on January 6, 2027
- All 10 director nominees re-elected
- Executive pay and KPMG’s fiscal 2027 appointment approved
- Proposal for an easier special-meeting right rejected
US$25 billion authorisation expands Lam’s capital-return capacity
Lam Research Corporation (NASDAQ:LRCX) has approved a US$25 billion authorisation to repurchase its common stock, adding to the remaining balance under previous programmes. The wafer fabrication equipment supplier also declared a quarterly dividend of US$0.33 a share, payable on January 6, 2027, to shareholders on the register on December 2.
The headline figure is substantial, but it is an authorisation rather than a binding purchase commitment. Lam can buy shares on-market or privately, use derivatives and structured repurchase agreements, or do nothing. The programme has no termination date and can be suspended or discontinued at any time. The announcement does not disclose the balance left under earlier authorisations, the timing of planned purchases or the amount ultimately likely to be spent.
Board links buyback to cash generation and technology demand
Chief financial officer Doug Bettinger said the authorisation reinforces Lam’s capital allocation plan and its commitment to return value through dividends and repurchases. He also pointed to the company’s positioning at “key technology inflections” and “robust cash generation” as supporting confidence in its capital-return objectives over time. Those comments are forward-looking rather than a forecast of a specific repurchase schedule.
For shareholders, the eventual effect will depend on execution: purchases could reduce the diluted share count and support per-share returns, but the filing gives no indication of the pace or price of any buyback. Future dividends remain subject to board approval, meaning the US$0.33 payment is declared but later distributions are not guaranteed.
Management-backed governance proposals pass with one exception
Lam’s annual meeting produced broad support for the existing governance structure. All 10 director nominees were elected, although support varied: Abhijit Y. Talwalkar received 87.99% of votes cast for, while Ita M. Brennan received 99.90%. Executive compensation was approved on an advisory basis with 93.12% support, and shareholders ratified KPMG as independent auditor for fiscal 2027 with 99.33% support.
The notable dissent came from a shareholder proposal seeking an attainable right to call a special shareholder meeting. It attracted 42.22% of votes cast for and was rejected, with 556.2 million votes against compared with 412.2 million in favour. The result leaves the existing framework unchanged, while the large buyback authorisation puts the focus on how much of the capital-return promise becomes visible in later share-count and cash-flow disclosures.
Bottom Line?
The US$25 billion ceiling strengthens Lam’s stated return-of-capital capacity, but subsequent repurchase activity, cash generation and diluted share count will determine whether it becomes a material shareholder outcome.
Questions in the middle?
- How quickly, and at what prices, will Lam convert the US$25 billion authorisation into actual repurchases?
- What balance remains under prior buyback authorisations, and how will total capital returns affect liquidity and share count?
- Will the rejected special-meeting proposal return in a future form, given its 42.22% support?